<?xml version="1.0" encoding="UTF-8"?>
<ref id="B285">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yeh</surname>
    <given-names>R. F.</given-names>
   </name>
   <name>
    <surname>Gaver</surname>
    <given-names>V. E.</given-names>
   </name>
   <name>
    <surname>Patterson</surname>
    <given-names>K. B.</given-names>
   </name>
   <name>
    <surname>Rezk</surname>
    <given-names>N. L.</given-names>
   </name>
   <name>
    <surname>Baxter-Meheux</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Blake</surname>
    <given-names>M. J.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2006</year>). 
  <article-title>Lopinavir/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers</article-title>. 
  <source>J. Acquir Immune Defic Syndr.</source>
  <volume>42</volume> (
  <issue>1</issue>), 
  <fpage>52</fpage>â€“
  <lpage>60</lpage>. 
  <pub-id pub-id-type="doi">10.1097/01.qai.0000219774.20174.64</pub-id>
  <pub-id pub-id-type="pmid">16639344</pub-id>
 </mixed-citation>
</ref>
